Felice Gadaleta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Felice Gadaleta has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Cristina Scoditti
Institute of Pulmonary Disease, University of Bari, Bari, Italy
2 shared publications - Mauro Maniscalco
Istituti Clinici Scientifici Maugeri IRCCS, Pulmonary Rehabilitation Unit of Telese Terme Institute, 82037 Telese Terme, Italy
2 shared publications - Onofrio Resta
Department of Basic Medical Sciences, Neurosciences and Sense Organs — Section of Respiratory Disease, University of Bari Aldo Moro, Bari, Italy
2 shared publications - Pierluigi Carratù
Internal Medicine “A. Murri”, University of Bari, 70121 Bari, Italy
2 shared publications - Anna Cassano
Institute of Pulmonary Disease, University of Bari, Bari, Italy
1 shared publication - Antonio Spanevello
Department of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy; Department of Medicine and Surgery, University of Insubria, Varese, Italy
1 shared publication
Latest Publications
- Open Access
- 10 March 2009
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 4 (1) , 10
Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease, which rapidly leads to chronic respiratory failure requiring mechanical ventilation. Currently, forced vital capacity (FVC) < 50% is considered as physiologic marker for admitting patients to Noninvasive Positive Pressure Ventilation (NPPV) intervention, although it has been recently shown the median survival of patients with baseline FVC < 75% much shorter than median survival of patients with baseline FVC > 75%, independently by any treatment.
- 10 March 2009
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 4 (1) , 10
Open AccessEarly treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease, which rapidly leads to chronic respiratory failure requiring mechanical ventilation. Currently, forced vital capacity (FVC) < 50% is considered as physiologic marker for admitting patients to Noninvasive Positive Pressure Ventilation (NPPV) intervention, although it has been recently shown the median survival of patients with baseline FVC < 75% much shorter than median survival of patients with baseline FVC > 75%, independently by any treatment.
- Open Access
- 26 September 2008
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 8 (1) , 20
Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension
Endothelin-1 (ET-1) and Nitric Oxide (NO) are crucial mediators for establishing pulmonary artery hypertension (PAH). We tested the hypothesis that their imbalance might also occur in COPD patients with PAH.
- 26 September 2008
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 8 (1) , 20
Open AccessExhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension
Endothelin-1 (ET-1) and Nitric Oxide (NO) are crucial mediators for establishing pulmonary artery hypertension (PAH). We tested the hypothesis that their imbalance might also occur in COPD patients with PAH.